Radius Health Announces Fourth Quarter and Full-Year 2018 Operating Results

Go back to Radius Health Announces Fourth Quarter and Full-Year 2018 Operating Results

Radius Health (RDUS) Tops Q4 EPS by 51c, Revenues Beat; Offers FY19 Revenue Mid-Point Guidance Below Consensus

February 28, 2019 4:30 PM EST

Radius Health (NASDAQ: RDUS) reported Q4 EPS of ($0.66), $0.51 better than the analyst estimate of ($1.17). Revenue for the quarter came in at $34.4 million versus the consensus estimate of $33.01 million.

I am very pleased with the continued strong performance of TYMLOS in the U.S.... More